SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William Blair 37th Annual Growth Stock Conference on June 13, 2017 at 2:10 p.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
